Human Genome Epidemiology Literature Finder
|
Records 1 - 14 (of 14 Records) |
| Query Trace: Ataxia and ATR[original query] |
|---|
| Mutation analysis of the ATR gene in breast and ovarian cancer families. Breast cancer research : BCR 2005 7 (4): R495-501. Heikkinen Katri, Mansikka Virpi, Karppinen Sanna-Maria, Rapakko Katrin, Winqvist Robe |
| Mutations in the ataxia telangiectasia and rad3-related-checkpoint kinase 1 DNA damage response axis in colon cancers. Genes, chromosomes & cancer 2007 Dec 46 (12): 1061-8. Lewis Kriste A, Bakkum-Gamez Jamie, Loewen Ralitsa, French Amy J, Thibodeau Stephen N, Cliby William |
| Assessing the prognostic role of ATR mutation in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic oncology 2015 Sep 138 (3): 614-9. Zighelboim Israel, Ali Shamshad, Lankes Heather A, Backes Floor, Moore Kathleen, Mutch David, Robison Katina, Behbakht Kian, Waggoner Steven, Ghebre Rahel G, Pearl Michael, Ramirez Nilsa C, Goodfellow Pa |
| A genome-wide analysis of gene-caffeine consumption interaction on basal cell carcinoma. Carcinogenesis 2016 Dec 37 (12): 1138-1143. Li Xin, Cornelis Marilyn C, Liang Liming, Song Fengju, De Vivo Immaculata, Giovannucci Edward, Tang Jean Y, Han Jia |
| Divergence of cAMP signalling pathways mediating augmented nucleotide excision repair and pigment induction in melanocytes. Experimental dermatology 2017 1 26 (7): 577-584. Wolf Horrell Erin M, Jarrett Stuart G, Carter Katharine M, D'Orazio John |
| Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2019 7 14 (11): 1924-1934. Goeman Frauke, De Nicola Francesca, Scalera Stefano, Sperati Francesca, Gallo Enzo, Ciuffreda Ludovica, Pallocca Matteo, Pizzuti Laura, Krasniqi Eriseld, Barchiesi Giacomo, Vici Patrizia, Barba Maddalena, Buglioni Simonetta, Casini Beatrice, Visca Paolo, Pescarmona Edoardo, Mazzotta Marco, De Maria Ruggero, Fanciulli Maurizio, Ciliberto Gennaro, Maugeri-Saccà Marcel |
| Clinicopathological significance of ataxia telangiectasia-mutated (ATM) kinase and ataxia telangiectasia-mutated and Rad3-related (ATR) kinase in MYC overexpressed breast cancers. Breast cancer research and treatment 2019 Feb . Savva Constantinos, De Souza Karen, Ali Reem, Rakha Emad A, Green Andrew R, Madhusudan Srinivas |
| BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers. Science translational medicine 2020 Feb 12 (531): . Coussy Florence, El-Botty Rania, Château-Joubert Sophie, Dahmani Ahmed, Montaudon Elodie, Leboucher Sophie, Morisset Ludivine, Painsec Pierre, Sourd Laura, Huguet Léa, Nemati Fariba, Servely Jean-Luc, Larcher Thibaut, Vacher Sophie, Briaux Adrien, Reyes Cécile, La Rosa Philippe, Lucotte Georges, Popova Tatiana, Foidart Pierre, Sounni Nor Eddine, Noel Agnès, Decaudin Didier, Fuhrmann Laetitia, Salomon Anne, Reyal Fabien, Mueller Christopher, Ter Brugge Petra, Jonkers Jos, Poupon Marie-France, Stern Marc-Henri, Bièche Ivan, Pommier Yves, Marangoni Elisabet |
| A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2021 12 163 19-26. Plummer Ruth, Dean Emma, Arkenau Hendrik-Tobias, Redfern Charles, Spira Alexander I, Melear Jason M, Chung Ki Y, Ferrer-Playan Jordi, Goddemeier Thomas, Locatelli Giuseppe, Dong Jennifer, Fleuranceau-Morel Patricia, Diaz-Padilla Ivan, Shapiro Geoffrey |
| Molecular Features in Lymphatic Metastases Reflect the Metastasis Mechanism of Lymph Nodes With Non-Small-Cell Lung Cancers. Frontiers in bioengineering and biotechnology 2022 10 909388. Guo Nannan, Chen Yuanyuan, Jing Zhongying, Liu Siyao, Su Junyan, Li Ruilin, Duan Xiaohong, Chen Zhigong, Chen Ping, Yin Rongjiang, Li Shaojun, Tang Ji |
| Olaparib and celarasertib (AZD6738) in patients with triple negative advanced breast cancer: results from Cohort E of the plasmaMATCH trial (CRUK/15/010). Clinical cancer research : an official journal of the American Association for Cancer Research 2023 9 . Alistair Ring, Lucy S Kilburn, Alex Pearson, Laura Moretti, Angelica Afshari-Mehr, Andrew M Wardley, Bora Gurel, Iain R Macpherson, Ruth Riisnaes, Richard D Baird, Sue Martin, Rebecca Roylance, Hannah Johnson, Ana Ferreira, Matthew C Winter, Kathryn Dunne, Ellen Copson, Tamas Hickish, Russell Burcombe, Kat Randle, Violeta Serra, Alba Llop-Guevara, Judith M Bliss, Nicholas C Turn |
| SETD2 loss and ATR inhibition synergize to promote cGAS signaling and immunotherapy response in renal cell carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 8 . Xian-De Liu, Yan-Ting Zhang, Daniel J McGrail, Xuesong Zhang, Truong Lam, Anh Hoang, Elshad Hasanov, Ganiraju Manyam, Christine B Peterson, Haifeng Zhu, Shwetha V Kumar, Rehan Akbani, Patrick G Pilie, Nizar M Tannir, Guang Peng, Eric Jonas |
| CHARIOT: a phase I study of berzosertib with chemoradiotherapy in oesophageal and other solid cancers using time to event continual reassessment method. British journal of cancer 2023 12 . S R Javed, S Lord, S El Badri, R Harman, J Holmes, F Kamzi, T Maughan, D McIntosh, S Mukherjee, A Ooms, G Radhakrishna, P Shaw, M A Hawki |
| Genotype-Directed Synthetic Cytotoxicity of ATR Inhibition with Radiotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 8 OF1-OF14. Victor Ng, Sonali Sinha, Ardijana Novaj, Jennifer Ma, Niamh McDermott, Xin Pei, Ana Leda F Longhini, Helen Grimsley, Rui Gardner, Ezra Rosen, Simon N Powell, Fresia Pareja, Diana Mandelker, Atif Khan, Jeremy Setton, Anne Roulston, Stephen Morris, Maria Koehler, Nancy Lee, Jorge Reis-Filho, Nadeem Ri |
- Page last reviewed:Feb 1, 2024
- Content source: